Vaxxinity, Inc. (VAXX)
OTCMKTS
· Delayed Price · Currency is USD
0.0150
-0.0005 (-3.23%)
Apr 29, 2025, 3:42 PM EDT
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $1.90 million as of April 30, 2025. Its market cap has decreased by -97.64% in one year.
Market Cap
1.90M
Enterprise Value
-13.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 1.90M, a decrease of -99.91%. That is a compound annual growth rate of -86.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 29, 2025 | 1.90M | 200.00% |
Dec 31, 2024 | 633.74K | -99.41% |
Dec 29, 2023 | 107.73M | -38.95% |
Dec 30, 2022 | 176.48M | -74.91% |
Dec 31, 2021 | 703.46M | -66.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.63B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 746.57M |
Glass House Brands | 500.84M |
Elite Pharmaceuticals | 450.22M |
Northwest Biotherapeutics | 443.51M |
CytoDyn | 284.32M |
BioStem Technologies | 245.41M |